Next Article in Journal
Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
Previous Article in Journal
The Combined Impact of CLIR Post-Analytical Tools and Second Tier Testing on the Performance of Newborn Screening for Disorders of Propionate, Methionine, and Cobalamin Metabolism
Open AccessArticle

Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care

Research Centre for Medical Genetics, 115522 Moscow, Russia
*
Author to whom correspondence should be addressed.
Int. J. Neonatal Screen. 2020, 6(2), 34; https://doi.org/10.3390/ijns6020034
Received: 26 January 2020 / Revised: 10 April 2020 / Accepted: 11 April 2020 / Published: 14 April 2020
In order to assess the effectiveness of the detection of cystic fibrosis (CF) patients by screening compared with diagnoses based on clinical manifestations, the data of the National CF Patient Registry (NCFPR) from the year 2012 (group I: children aged 6–9 years, diagnosed prior to the start of screening) were compared with the data in the NCFPR from the year 2015 (group II: children 6–9 years after the start of screening) for CF patients from the Moscow region. Homozygotes for c.1521_1523delCTT (F508del) were separately compared in both groups. The average diagnosis age, genotype, body mass index, spirometry data, pulmonary infection, medications, and presence of complications were analyzed. This study demonstrated that in the c.1521_1523delCTT (F508del) homozygote group, the patients diagnosed by screening had significant advantages over the patients born before the start of newborn screening in the diagnosis age, the number of patients with chronic Pseudomonas aeruginosa infection, the pulmonary function, and the growth in the percentiles. Newborn screening (NBS) detects nearly twice as many CF patients as the diagnostics based on clinical symptoms during the same time period. Importantly, patients will benefit from the early diagnosis of the disease and the early start of therapy. View Full-Text
Keywords: cystic fibrosis; newborn screening; IRT; sweat test cystic fibrosis; newborn screening; IRT; sweat test
Show Figures

Figure 1

MDPI and ACS Style

Sherman, V.; Kondratyeva, E.; Kashirskaya, N.; Voronkova, A.; Nikonova, V.; Zhekaite, E.; Kutsev, S. Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care. Int. J. Neonatal Screen. 2020, 6, 34.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop